BK Kim, N Tamaki, K Imajo, M Yoneda, N Sutter… - Journal of …, 2022 - Elsevier
Background & Aims Patients with non-alcoholic fatty liver disease (NAFLD) and significant
fibrosis (fibrosis stage≥ 2) are candidates for pharmacological trials. The aim of this study …